Example: marketing
Package leaflet: Information for the user Avamys …
1 Package leaflet: Information for the user Avamys 27.5 micrograms per spray nasal spray suspension Fluticasone furoate . Read all of this leaflet carefully before you start using this medicine because it contains important
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
Package leaflet: Information for the user Clexane …
www.medicines.org.uk1 Package leaflet: Information for the user. Clexane® Syringes 2,000 IU (20 mg)/0.2 ml solution for injection in pre-filled syringes . Clexane® Syringes 4,000 IU (40 mg)/0.4 ml solution for injection in pre-filled syringes
small pharma code may appear on the front / back …
www.medicines.org.ukKeep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the blister and carton after EXP.
PACKAGE LEAFLET: INFORMATION FOR THE USER
www.medicines.org.uk1.3.1. Package Leaflet 1 PACKAGE LEAFLET: INFORMATION FOR THE USER CALCEOS 500mg/400IU CHEWABLE TABLETS …
PACKAGE LEAFLET: INFORMATION FOR THE USER
www.medicines.org.uk1.3.1 Package Leaflet 1 Package leaflet: Information for the patient Laxido Orange, powder for oral solution. Read all of this leaflet carefully before you start taking this medicine because it contains
Package leaflet: Information for the user - Medicines
www.medicines.org.ukPage 1 of 8 v019_0 Due to regulatory changes, the content of the following Patient Information Leaflet may vary from the one found in your medicine pack.
Package leaflet: Information for the user …
www.medicines.org.ukRead all of this leaflet carefully before you start taking this medicine because it contains important information for you. • Keep this leaflet.
PFIZER Package leaflet: Information for the patient …
www.medicines.org.ukPage 1 of 20 PFIZER Package leaflet: Information for the patient Depo-Provera® 150 mg/ml Sterile Suspension for Injection Medroxyprogesterone acetate Please read all of this leaflet carefully before you start using this medicine because it
SAYANA PRESS 104 mg/0.65 ml suspension for …
www.medicines.org.ukPage 1 of 15 Package leaflet: Information for the user SAYANA PRESS® 104 mg/0.65 ml suspension for injection medroxyprogesterone acetate Single-dose container ...
PACKAGE LEAFLET: INFORMATION FOR THE USER …
www.medicines.org.ukPACKAGE LEAFLET: INFORMATION FOR THE USER Bisoprolol 2.5 mg Film-coated Tablet Bisoprolol 5 mg Film-coated Tablet Bisoprolol 10 mg Film-coated Tablet
Patient Information Leaflet - Medicines
www.medicines.org.ukPage 2 of 10 Patient Information Leaflet Salazopyrin® EN-tabs 500 mg enteric-coated tablets sulfasalazine In this leaflet: 1. What Salazopyrin EN …
Related documents
Nicotrol NS DESCRIPTION - Pfizer
www.pfizer.comNicotrol®NS (nicotine nasal spray) 10 mg/mL DESCRIPTION Nicotrol® NS (nicotine nasal spray) is an aqueous solution of nicotine intended for administration as a metered spray to the nasal mucosa.
Pack insert Cortyzine nasal spray a 15mL-p1-p2
takeda-kenko.jpTitle: Pack insert Cortyzine nasal spray a 15mL-p1-p2 Author: prepresstenbunPRO6 Created Date: 6/1/2017 10:03:19 AM
2015.06.16 Alanase DS - Medsafe
www.medsafe.govt.nzPage 1 of 5 NEW ZEALAND DATA SHEET ALANASE Beclometasone dipropionate Aqueous Nasal Spray 50 µg & 100 µg per actuation Presentation ALANASE Aqueous Nasal Spray (50 micrograms per actuation) is an almost white opaque suspension of
PRODUCT INFORMATION ZYRTEC LEVOCABASTINE …
www.medicines.org.auPage 2 of 7 February 2017 Pharmacokinetics After intranasal and ocular application, the absorption of levocabastine is incomplete with a systemic bioavailability ranging from 60 to 80% for the nasal spray and from 30 to 60% for the
2016.07.20 Butacort DS - Medsafe Home Page
www.medsafe.govt.nzPage 2 of 6 BUTACORT 100 Aqueous Nasal Spray is also indicated for the symptomatic relief of nasal polyposis. Dosage and Administration BUTACORT 50
XHANCE™ Full Prescribing Information
www.xhance.comFULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE XHANCE™ nasal spray is indicated for the treatment of nasal polyps in patients 18 years of age or older.